Aggressive treatment for statin-induced necrotizing autoimmune myopathy yielded limited recovery, highlighting therapeutic uncertainty and a lack of standardized guidelines.
This case report highlights the therapeutic uncertainty and limited recovery associated with statin-induced necrotizing autoimmune myopathy despite aggressive treatment.
Absolute Event Rate: 0% vs 0%
To present a case of Statin-induced necrotizing autoimmune myopathy (SINAM) in the absence of standardized guidelines.
Chacón et al. (Tue,) reported a other. Aggressive treatment for statin-induced necrotizing autoimmune myopathy yielded limited recovery, highlighting therapeutic uncertainty and a lack of standardized guidelines.